ALS biomarker hunt aims to boost failed drug trials
NCT ID NCT02360891
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study of 500 people with ALS (Lou Gehrig's disease) aimed to find biological signs, or biomarkers, that can predict how the disease will progress. Researchers collected clinical, imaging, and lab data to better understand different forms of ALS. The goal is to help future drug trials select the right patients and improve chances of success.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help identify which patients might respond to certain treatments, making future ALS drug trials more effective.
What could go wrong
This is an observational study, not a treatment trial. It may not directly lead to new therapies, and the biomarkers found may not be reliable enough to change clinical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HM,Hôpital de la Timone
Marseille, France
-
CHRU, Hôpital Salengro
Lille, France
-
CHU Bretonneau
Tours, France
-
CHU Cote de Nacre
Caen, France
-
CHU Gabriel Montpied
Clermont-Ferrand, France
-
CHU Pontchaillou
Angers, France
-
Centre Hospitalier
Saint-Brieuc, France
-
Hôpital Dupuytren
Limoges, France
-
Hôpital Gui de Chauliac
Montpellier, France
-
Hôpital La Pitié (AP-HP)
Paris, France
-
Hôpital Neurologique Pierre Wertheimer
Lyon, France
-
Hôpital Nord
Saint-Etienne, France
-
Hôpital de l'Archet 1, CHU
Nice, France